📰 Nasdaq Prof News
Page 2 - Nasdaq Prof News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Prof. Real-time updates on events, politics, business and more.
June 20, 2023
Profound Medical Corp. (NASDAQ:PROF – Get Rating) – Analysts at Raymond James issued their FY2027 earnings per share (EPS) estimates for Profound Medical in a research note issued on Thursday, June 15th. Raymond James analyst R. Sarugaser forecasts that the company will post earnings of $2.87 per share for the year. Raymond James currently has […]
June 8, 2023
Profound Medical (NASDAQ:PROF – Get Rating) had its target price boosted by Raymond James from $17.00 to $20.00 in a report published on Monday morning, BayStreet.CA reports. They currently have a strong-buy rating on the stock. Separately, Jefferies Financial Group lowered shares of Profound Medical from a buy rating to a hold rating and boosted […]
May 9, 2023
Profound Medical (NASDAQ:PROF – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 10th. Analysts expect Profound Medical to post earnings of ($0.32) per share for the quarter. Profound Medical (NASDAQ:PROF – Get Rating) last released its quarterly earnings data on Tuesday, March 7th. The company […]
March 25, 2023
Jefferies Financial Group cut shares of Profound Medical (NASDAQ:PROF – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Marketbeat.com reports. The brokerage currently has $10.00 target price on the stock, up from their prior target price of $5.50. Jefferies Financial Group also issued estimates for Profound Medical’s […]
May 26, 2022
Equities research analysts predict that Profound Medical Corp. (NASDAQ:PROF – Get Rating) will report $2.00 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Profound Medical’s earnings. Profound Medical reported sales of $2.63 million in the same quarter last year, which indicates a negative year […]
May 4, 2022
Equities analysts forecast that Profound Medical Corp. (NASDAQ:PROF – Get Rating) will post ($0.45) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Profound Medical’s earnings, with estimates ranging from ($0.52) to ($0.38). Profound Medical posted earnings of ($0.37) per share during the same quarter […]
April 25, 2022
Profound Medical (NASDAQ:PROF – Get Rating) has been given a $22.00 price objective by research analysts at Raymond James in a report issued on Monday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ price target points to a potential upside of 195.30% from the company’s previous close. Several other […]
April 15, 2022
Wall Street analysts predict that Profound Medical Corp. (NASDAQ:PROF – Get Rating) will report sales of $1.50 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Profound Medical’s earnings. Profound Medical reported sales of $710,000.00 in the same quarter last year, which indicates a positive year-over-year growth rate of 111.3%. […]
March 25, 2022
Profound Medical (NASDAQ:PROF – Get Rating) had its target price reduced by Raymond James from $23.00 to $22.00 in a report published on Monday morning, BayStreet.CA reports. Raymond James currently has an outperform rating on the stock. PROF has been the topic of a number of other reports. Zacks Investment Research cut Profound Medical from […]
March 5, 2022
Profound Medical (NASDAQ:PROF – Get Rating) issued its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by ($0.14), MarketWatch Earnings reports. Profound Medical had a negative net margin of 320.56% and a negative return on equity of 30.45%. During the […]